Background and Objectives: Hypertrophic cardiomyopathy (HCM) depends on the primary impairment of sarcomeres, but it can also be associated with secondary alterations in the heart related to oxidative stress. The present study aimed to examine oxidative-antioxidant disturbances in patients with HCM compared with control individuals. Materials and Methods: We enrolled 52 consecutive HCM patients and 97 controls without HCM. The groups were matched for age, body mass index, and sex. Peripheral blood was collected from all patients to determine the total antioxidant capacity (TAC), total oxidant status (TOS), lipid hydroperoxide (LPH), and malondialdehyde (MDA). The oxidative stress index (OSI) was defined as the ratio of the TOS level to the TAC level. Results: The median age was 52 years, and 58.4% were female. The area under the curve (AUC) indicated good predictive power for the TAC and TOS [AUC 0.77 (0.69–0.84) and 0.83 (0.76–0.90), respectively], as well as excellent predictive power for the OSI [AUC 0.87 (0.81–0.93)] for HCM detection. Lipid peroxidation markers also demonstrated good predictive power to detect HCM patients [AUCLPH = 0.73, AUCMDA = 0.79]. Conclusions: The TOS, the TAC, LPH levels, and MDA levels have good predictive power for HCM detection. The holistic assessment of oxidative stress by the OSI had excellent power and could identify patients with HCM.

HF and is considered one of key contraindications to orthotopic heart transplant (OHT). 2,9 Reversing increased pulmonary capillary pressure represents a therapeutic challenge, which would make OHT-a final resolution of congestive HF-possible. There have been few studies that analyzed the impact of CF-LVAD implantation on pulmonary pressure and resistance. Some authors INTRODUCTION A constant increase in the number of patients with end-stage heart failure (HF) and a shortage of heart donors worldwide implies a wider use of mechanical circulatory support, mainly continuous-flow left ventricular assist devices (CF-LVADs).

Purpose -The purpose of this paper is to estimate the influence of long-term, whole-body exposure of rats to strong, static electric field with physical parameters generated nearby high voltage direct current (HVDC) transmission lines on the intensity of reactive oxygen species generation analyzed indirectly, basing on the measurement of malone dialdehyde level, as well as on the activity of enzymatic antioxidant defence system. Design/methodology/approach -In rats exposed to static electric field with intensity of 16, 25 and 35 kV/m, respectively, or sham-exposed eight hours daily for 56 days, in the obtained plasma, erythrocytes lysates and liver homogenates the activity of some antioxidant enzymes as well as the concentration of malone dialdehyde were determined with use of spectrophotometric and kinetic methods. Findings -It was observed that long-term exposure of rats to static electric field causes only temporary compensatory changes in the concentration of malone dialdehyde and transient changes in the activity of enzymatic antioxidant system, both in blood and in liver tissue in the form of temporary inhibition of activity of most antioxidant enzymes during exposure cycle, with subsequent compensatory increase in this activity after the end of exposure cycle, enabling maintenance of prooxidant-antioxidant balance in the organism of experimental animals and inhibition of peroxidation process. Practical implications -Presented data indicate that construction of air HVDC transmission lines, according to actual compulsory regulations, enables serious health hazards related to persistent disturbances of prooxidant-antioxidant balance to be avoided. Originality/value -In the experiment it was confirmed, for the first time, that long-term exposure to strong static electric field causes transient compensatory changes of prooxidant-antioxidant balance in living organisms.

No abstract

Left ventricular assist device (LVAD) is well established as an alternative treatment for end-stage heart failure (HF) patients. The aim of the study was to determine the prognostic value of oxidative stress markers and the modified Model for End-Stage Liver Disease (modMELD) in patients receiving bridged therapy with continuous-flow LVAD. We prospectively analyzed 36 end-stage HF patients who received LVAD therapy between 2015 and 2018. The total antioxidant capacity (TAC) and total oxidant status (TOS) were measured by the methods described by Erel. The oxidative stress index (OSI) was defined as the ratio of the TOS to TAC levels. The modMELD scores were calculated based on the serum bilirubin, creatinine, and albumin levels. The patients’ median age was 58 (50–63.0) years. During the 1.5-years follow-up, a major adverse cardiac event—MACE (death, stroke, or pump thrombosis) was observed in 17 patients (47.2%). The area under the receiver operating characteristics curves (AUCs) indicated a good prognostic power of TAC (AUC 0.7183 (0.5417–0.8948)), TOS (AUC 0.9149 (0.8205–0.9298)), OSI (AUC 0.9628 (0.9030–0.9821)), and modMELD (AUC 0.87 (0.7494–0.9905)) to predict a MACE. Oxidative stress markers serum concentrations, as well as the modMELD score, allow the identification of patients with a risk of MACE.